Certificate under SEBI (Depositories and Participants) Regulations, 2018

Shilpa Medicare Limited Corporate & Admin Office: “Shilpa House”, # 12-6-214/A-1, Hyderabad Road, Raichur – 584 135, Karnataka, India Tel: +91-8532-238704, Fax: +91-8532-238876 Email: info@vbshilpa.com, Web: www.vbshilpa.com CIN: L85110KA1987PLC008739 Date: 07 October 2026 To To The Corporate Relationship Department National Stock Exchange of India Ltd. BSE Limited Exchange Plaza, C-1, Block G, Phiroze Jeejeebhoy Towers Bandra Kurla Complex, Dalal Street Bandra (E) Mumbai- 400 001 Mumbai – 400 051 Ref. - SCRIP CODE & SYMBOL: 530549, SHILPAMED Dear Sir/ Madam, Sub: Submission in compliance with Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026. Pursuant to Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, Please find enclosed a Certificate dated 02 October 2026 received from “M/s. Kfin Technologies Limited” (SEBI Registration No. INR000000221), the Registrar and Share Transfer Agent of Shilpa Medicare Limited for the quarter ended September 30, 2026. This is for your information and records. Thanking you, For and on behalf of Shilpa Medicare Limited Ritu Tiwary Company Secretary & Compliance officer Encl.: Certificate under Regulation 74(5) for the quarter ended September 30, 2026. KFIN/SML/CDSL/74(5) E/1 Date: 02‐10‐2026 CENTRAL DEPOSITORY SERVICES (INDIA) LIMITED REGD OFF: MARATHON FUTUREX, A WING 25TH FLOOR NM JOSHI MARG LOWER PAREL (EAST) MUMBAI ‐ 400 023 Dear Sir(s), Sub: Certificate under Regulation 74(5) for the quarter ended September 30,2026 We as Registrar to an Issue and Share Transfer Agent of the SHILPA MEDICARE LTD, certify that the details of securities dematerialized/rematerialized during the aforesaid period, as required under Regulation 74(5) of SEBI (Depositories and participants) Regulations 2018 have been furnished to all the Stock Exchanges where the shares of the company are listed. Thanking You Yours faithfully, for KFIN TECHNOLOGIES LIMITED C SHOBHA ANAND VICE PRESIDENT CC TO: SHILPA MEDICARE LTD 1ST FLOOR, 10/80 RAJENDRA GUNJ RAICHUR 584102 KFIN/SML/NSDL/74(5) E/1 Date: 02‐10‐2026 NATIONAL SECURITIES DEPOSITORY LIMITED TRADE WORLD 4TH FLOOR KAMALA MILLS COMPOUND SENAPATI BAPAT MARG LOWER PAREL MUMBAI ‐ 400 013 Dear Sir(s), Sub: Certificate under Regulation 74(5) for the quarter ended September 30,2026 We as Registrar to an Issue and Share Transfer Agent of the SHILPA MEDICARE LTD, certify that the details of securities dematerialized/rematerialized during the aforesaid period, as required under Regulation 74(5) of SEBI (Depositories and participants) Regulations 2018 have been furnished to all the Stock Exchanges where the shares of the company are listed. Thanking You Yours faithfully, for KFIN TECHNOLOGIES LIMITED C SHOBHA ANAND VICE PRESIDENT CC TO: SHILPA MEDICARE LTD 1ST FLOOR, 10/80 RAJENDRA GUNJ RAICHUR 584102